/

Workspace

Research & Review

Writing & Publishing

Data & Analysis

Utilities

Account

User Settings

P

Pietro Scilipoti

Vita-Salute San Raffaele University(IT)

Claim or correct this author profile

Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.

160

Papers

371

Citations

11

h-index

12

i10-index

Pietro Scilipoti is an academic researcher from Vita-Salute San Raffaele University. The author has contributed to research in topics: Bladder and Urothelial Cancer Treatments & Urinary and Genital Oncology Studies & Prostate Cancer Diagnosis and Treatment. The author has an h-index of 11, co-authored 136 publications.

ORCID: 0009-0007-6126-9889

Research Topics

Bladder and Urothelial Cancer Treatments Urinary and Genital Oncology Studies Prostate Cancer Diagnosis and Treatment Prostate Cancer Treatment and Research Renal cell carcinoma treatment

Papers by this author

works

Time for action: actinium-225 PSMA-targeted alpha therapy for metastatic prostate cancer - a systematic review and meta-analysis

2025 · Theranostics · 19 citations

https://doi.org/10.7150/thno.106574

Gaia Ninatti Pietro Scilipoti Cristiano Pini Francesco Barletta

Outcomes of <scp>BCG</scp> vs upfront radical cystectomy for high‐risk non‐muscle‐invasive bladder cancer

2025 · British Journal of Urology · 10 citations

https://doi.org/10.1111/bju.16675

Pietro Scilipoti Mattia Longoni Mario de Angelis Paolo Zaurito

The Impact of Second Opinion Expert Pathology Review in Patient Management at the Time of Transurethral Resection of the Bladder

2024 · European Urology Focus · 9 citations

https://doi.org/10.1016/j.euf.2024.06.007

Daniele Robesti Marco Moschini Nazario Pio Tenace Giusy Burgio

Incidence and prognostic implications of prostate-specific antigen persistence and relapse after radical prostatectomy: population-based study

2025 · JNCI Journal of the National Cancer Institute · 8 citations

https://doi.org/10.1093/jnci/djaf012

Pietro Scilipoti Hans Garmo Rolf Gedeborg David Robinson

Improved adherence to prostate cancer guidelines concomitant with public reporting. Nationwide population-based study

2025 · Scandinavian Journal of Urology · 4 citations

https://doi.org/10.2340/sju.v60.43107

Andri Wilberg Orrason Pietro Scilipoti Hans Garmo Rolf Gedeborg

Efficacy and Safety of Checkpoint Inhibitors Combined with Bacillus Calmette-Guérin (BCG) in BCG-naïve High-risk Non–muscle-invasive Bladder Cancer: Synthesis of Evidence from the ALBAN, CREST, and POTOMAC Trials

2025 · European Urology · 2 citations

https://doi.org/10.1016/j.eururo.2025.12.022

Pietro Scilipoti Paolo Zaurito Mattia Longoni Maurizio Colecchia

Research topics

topics

Bladder and Urothelial Cancer Treatments

Urinary and Genital Oncology Studies

Prostate Cancer Diagnosis and Treatment

Prostate Cancer Treatment and Research

Renal cell carcinoma treatment

Chat about Author

Papers

Chat

Click to start Chat